April 7, 2016 – This is further to the CPMA notice to industry dated March 31st, 2016, respecting the delayed implementation of the 2016 Elimination Guidelines.
We have received a number of inquiries from industry participants asking about the changes to the withdrawal guidelines for the drugs Clenbuterol and Methylprednisolone.
This memo confirms that as mentioned in our March 31st, 2016 notice, official samples will be tested and certificates will be issued for results inconsistent with the Schedule of Drugs 2011 guidelines. This includes the guidelines for Clenbuterol and Methylprednisolone.
Given the number of changes made to in the 2016 Elimination Guidelines, we believe this to be the most equitable approach to adopt for the transition period.
However, the CPMA reiterates that this approach is being taken in order to assist the industry in transitioning to the new guidelines and urges all industry participants to adjust their practices so as to comply with the new 2016 Elimination Guidelines, which will come into effect on May 1st, 2016.
For further information, contact the CPMA toll free at 1-800-268-8835 or by Email: email@example.com.